Medicare's GLP-1 Bridge Program
Who Qualifies and How to Get Approved
If you’ve heard that Medicare is now helping some people access GLP-1 medications for weight management, you may be wondering: Do I qualify, and how do I get approved?
The new Medicare GLP-1 Bridge may help. The Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge on July 1, 2026. It is a temporary Medicare demonstration program designed to give certain people with Medicare Part D access to specific GLP-1 medications for weight management. The program is currently scheduled to continue through December 31, 2027.
Who Can Qualify for the Medicare GLP-1 Bridge?
Having Medicare alone does not automatically make someone eligible. First, the individual must have qualifying Medicare Part D prescription drug coverage, such as an eligible standalone Part D prescription drug plan or Medicare Advantage plan that includes prescription drug coverage.
The medication must also be prescribed to reduce excess body weight and maintain weight reduction, along with ongoing lifestyle changes that include structured nutrition and physical activity. In addition, the individual must meet one of the following clinical requirements at the time GLP-1 therapy was started:
BMI of 35 or higher
An adult with a BMI of 35 or greater may qualify without one of the additional medical conditions listed below.
BMI of 30 or higher plus certain health conditions
An adult with a BMI of at least 30 may qualify if they also have at least one of the following:
Heart failure with preserved ejection fraction
Uncontrolled high blood pressure despite treatment with two blood-pressure medications
Chronic kidney disease, stage 3a or higher
BMI of 27 or higher plus certain health conditions
An adult with a BMI of at least 27 may qualify if they also have at least one of the following:
Prediabetes
A previous heart attack
A previous stroke
Symptomatic peripheral artery disease
These are specific CMS clinical requirements, so simply having a BMI over 27 does not automatically qualify someone for the program.
What If You Have Already Lost Weight on a GLP-1?
This is an important part of the program. CMS looks at whether the individual met the clinical criteria when GLP-1 therapy was originally started, not necessarily their BMI today.
For example, someone who began treatment with a BMI of 37 but now has a BMI of 33 because the medication helped them lose weight may still meet the BMI requirement. The physician can attest to the qualifying BMI at the time therapy began.
What Medications Are Included?
As of September 2026, CMS lists certain formulations of Foundayo®, Wegovy® and Zepbound® as eligible medications under the Bridge program. Not every formulation is included, and CMS may update the list during the program. For someone who qualifies, the copay for a covered medication through the Bridge is $50 for a covered monthly supply.
Because the Bridge operates outside the regular Medicare Part D benefit, the $50 does not count toward the Part D deductible or the beneficiary’s Part D out-of-pocket costs.
How Does Someone Get Into the GLP-1 Bridge?
This is where the process can get confusing. There isn't a separate application that a Medicare beneficiary simply fills out and sends to Medicare. The process begins with the healthcare provider and pharmacy. The order of the steps matters.
Step 1: Talk With Your Healthcare Provider
The first step is talking with the physician or other qualified prescriber. The provider will need to determine whether the medication is medically appropriate and whether the patient appears to meet the Medicare GLP-1 Bridge clinical requirements.
Step 2: The Physician Sends the Prescription to the Pharmacy
If the provider determines that the patient may qualify, the provider sends a prescription for an eligible GLP-1 medication to the pharmacy. The prescription should be sent to the pharmacy before the physician submits the Bridge prior authorization. This is an important difference from many traditional prior authorization processes.
Step 3: The Pharmacy Processes the Prescription
The pharmacy submits the claim to the Medicare GLP-1 Bridge. This initial pharmacy claim helps establish the patient in the Bridge system and determines whether a prior authorization is required. The pharmacy will then generally transmit the prior authorization request to the prescriber electronically or by fax. CMS says this will typically occur within 24 to 72 hours.
Step 4: The Physician Completes the Prior Authorization
Once the pharmacy has initiated the process, the physician completes the Medicare GLP-1 Bridge prior authorization. The provider will need to attest that the patient meets the appropriate clinical requirements, including the qualifying BMI and, when applicable, the qualifying medical condition. The provider must also attest that the medication is being prescribed for weight reduction and maintenance along with ongoing lifestyle modification that includes structured nutrition and physical activity. CMS strongly encourages providers to submit the prior authorization electronically, although it can also be submitted by fax.
An Important Warning for Physicians
Do not submit the Bridge prior authorization before the pharmacy processes the prescription.
CMS specifically instructs prescribers to send the prescription to the pharmacy and wait for the pharmacy to request the prior authorization. If the physician attempts to submit the prior authorization before a pharmacy claim has established the patient in the Medicare GLP-1 Bridge system, the physician may receive a “patient not found” error.
Step 5: The Prior Authorization Is Reviewed
After the completed prior authorization is submitted, a decision is generally communicated to the physician electronically or by fax and mailed to the patient within 72 hours of submission. If approved, the pharmacy can process the medication through the Medicare GLP-1 Bridge. Once the first fill has been approved, additional fills generally do not require another prior authorization through the end of the Bridge program. However, if the patient switches from one covered GLP-1 medication to another, a new prior authorization is required.
What If the Physician Doesn't Receive the Prior Authorization Request?
If the pharmacy has processed the prescription, but the physician has not received the prior authorization request after 72 hours, CMS says the physician may download the Medicare GLP-1 Bridge prior authorization form and submit it directly. Prescribers who have questions about a Bridge prior authorization can also contact the Medicare GLP-1 Bridge Call Center at 855-273-0102, Monday through Friday, 8 a.m. to 7 p.m. Eastern Time.
What About GLP-1s for Diabetes or Other Conditions?
The Medicare GLP-1 Bridge was specifically created to provide access to qualifying GLP-1 medications for weight management. Some GLP-1 medications may already be covered by Medicare Part D when prescribed for certain FDA-approved indications.
CMS specifically identifies type 2 diabetes, moderate-to-severe obstructive sleep apnea, and certain cases of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) as indications that may be eligible for Part D coverage rather than the Bridge.
A beneficiary with one of these diagnoses is not eligible to receive the medication through the Bridge for that condition even if the person's Part D plan does not cover the particular GLP-1 medication.
The Process in Plain English
Think of the Medicare GLP-1 Bridge process this way:
Doctor determines that you may qualify → Doctor sends the prescription to the pharmacy → Pharmacy processes the prescription through the Bridge → Pharmacy requests prior authorization → Doctor completes the Bridge prior authorization → Bridge reviews the request → If approved, the pharmacy fills the prescription.
The biggest thing to remember is that the prescription goes to the pharmacy first.
Think You Might Qualify?
The Medicare GLP-1 Bridge gives some Medicare beneficiaries a new pathway to access GLP-1 medications for weight management, but the eligibility requirements are very specific.
Your physician or other healthcare provider will determine whether the medication is medically appropriate and whether you meet the clinical requirements for the program.
You can also learn more directly from Medicare and CMS: Medicare GLP-1 Bridge information:
Medicare: 1-800-MEDICARE (1-800-633-4227)
As a licensed independent health insurance agent, I help people understand their Medicare coverage and how programs such as the Medicare GLP-1 Bridge work with their Medicare benefits. If you have questions about your Medicare coverage, I would be happy to help.
This information is for educational purposes and is based on CMS guidance available as of September 2026. Eligibility and medical treatment decisions are determined by the Medicare GLP-1 Bridge program and the individual's healthcare providers. Program requirements and covered medications may change.
Comments